Obseva SA (NASDAQ:OBSV)

2.67
Delayed Data
As of Aug 07
 -0.025 / -0.93%
Today’s Change
1.63
Today|||52-Week Range
10.35
-30.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$131.8M

Company Description

ObsEva SA engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland.

Contact Information

ObsEva SA
Chemin des Aulx, 12
Geneva Geneve (geneva) 1228
P:(122) 552-3840
Investor Relations:

Employees

Shareholders

Mutual fund holders7.55%
Other institutional13.44%
Individual stakeholders--

Top Executives

Ernest LoumayeChief Executive Officer & Director
Fabien de LadonchampsChief Financial Officer
Jean-Pierre GottelandChief Scientific Officer
Elizabeth Ijeoma Onyemelukwe GarnerChief Medical Officer
Elke BestelVP, Head-Drug Safety & Pharmacovigilance